Neuroendocrine Differentiation in Prostate Cancer: Implications for New Treatment Modalities-Reference-Cited by-同舟云学术

Neuroendocrine Differentiation in Prostate Cancer: Implications for New Treatment Modalities

Published:2005-02 Issue:2 Volume:47 Page:147-155
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Vashchenko Nadezda,Abrahamsson Per-Anders

Publisher

Elsevier BV

Subject

Urology

Reference84 articles.

1. Murphy G, Griffiths K, Denis L, Khoury S, Chatelain C, Cocklett ATK. Epidemiology and natural history of prostate cancer. Proceedings of the First International Consultation on Prostate Cancer, June 20, 1996. Manchecourt: Scientific Communication International; 1997.

2. The evolution of an epidemic of unknown origin;Boyle,1994

3. Cancer Statistics, 1998;Landis;CA Cancer J Clin.,1998

4. National Cancer Institute roundtable on prostate cancer: Future research directions;Chiarado;Cancer Res.,1991

5. The endocrinology and developmental biology of the prostate;Cunha;Endocr Rev.,1987

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell sequencing revealed metabolic reprogramming and its transcription factor regulatory network in prostate cancer;Translational Oncology;2024-06

2. Overexpression of REST Represses the Epithelial–Mesenchymal Transition Process and Decreases the Aggressiveness of Prostate Cancer Cells;International Journal of Molecular Sciences;2024-03-15

3. Tumor protein D52 (isoform 3) induces NF-κB – STAT3 mediated EMT driving neuroendocrine differentiation of prostate cancer cells;The International Journal of Biochemistry & Cell Biology;2024-01

4. PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review;Cancers;2023-09-03

5. Transformable Neuropeptide Prodrug with Tumor Microenvironment Responsiveness for Tumor Growth and Metastasis Inhibition of Triple‐Negative Breast Cancer;Advanced Science;2023-05-05